May 22, 2020
Hikma receives FDA approval for its generic Vascepa®
Dec 13, 2019
Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
Nov 19, 2019
Why Oncology Drugs are Projected to Generate the Largest Pharma Revenues
Aug 14, 2019
Non-Invasive Cellulite Treatments and Devices Dominating Billion Dollar Market
Jul 10, 2019
Biotech Brief: Researchers Looking at New Bundled Treatment Options for Leukemia
Mar 18, 2019
Vascepa® (icosapent ethyl) Showed 30% Reduction in Total Cardiovascular Events Including Recurrent Events in REDUCE-IT(TM)
Mar 15, 2019
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Amarin Corporation To Contact The Firm
Mar 04, 2019
U.S. Medical Device Market Reaches $156 Billion Mark
Feb 25, 2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amarin Corporation plc - AMRN
Nov 28, 2018
Cardax Names Former Amarin Head of Development Paresh N. Soni, MD, PhD, to lead Clinical and Regulatory Strategy
Nov 13, 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN
Sep 26, 2018
Key Treatments and Latest Medical Advancements Reshaping Cardiovascular Drugs Market for Increasing Gains
Mar 14, 2018
Quotidian Technical Highlights on Selected Drug Makers Stocks -- Amarin, Apricus Biosciences, United Therapeutics, and Novo Nordisk
Nov 08, 2017
Drug Makers Stock Performance Review -- Amarin, Endo, Ionis Pharma, and Teva Pharma
Sep 14, 2017
CRN Decries Harm to Public Interest and Calls Out Significant Legal Deficiencies in Amarin Pharma Complaint against Omega-3 Companies